Abstract
The loss of ovarian estrogen production in postmenopausal women causes vaginal dryness and irritation. The contraceptive depot-medroxyprogesterone acetate (DMPA) likewise promotes vaginal dryness by suppressing ovulation and reducing estrogen production. Though vaginal dryness in women is typically identified by self-report, research with preclinical models will benefit from development of new methodology that objectively measures vaginal moisture. Strips of calibrated filter paper, similar to those used to quantify lachrymal secretions, were intravaginally placed in untreated ovary-intact mice, DMPA-treated ovary-intact mice, and ovariectomized (OVX) mice to measure vaginal fluid levels. As anticipated, levels of circulating estradiol were significantly lower in DMPA-treated and OVX mice vs. estrus-stage mice. Congruent with the loss of estrogen, median readings on calibrated filter paper strips collected from DMPA-treated (1 mm) and OVX mice (1 mm) were significantly lower than the median reading from estrus-stage mice (10 mm); (P < 0.0001 for both comparisons). Current findings indicate that calibrated filter paper provides objective measure of vaginal moisture in mice and suggest that the hypoestrogenemia produced in mice by DMPA injection or ovariectomization models the vaginal dryness detected in women with reduced levels of circulating estrogen.